2 ASX tech shares that are rapidly growing

Cettire is an ASX share that is seeing a high level of growth.

| More on:
chart showing an increasing share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Digital ASX shares are achieving strong revenue growth
  • Both Doctor Care Anywhere and Cettire are seeing triple digit revenue growth
  • The two stocks are investing and further expanding their addressable markets

There are a select few ASX tech shares that are experiencing a high level of growth year on year.

Businesses that are growing at a very fast pace can often capture investor attention.

Depending on their long-term trajectory, they may end up becoming much larger over time.

Doctor Care Anywhere Plc (ASX: DOC)

The Doctor Care Anywhere share price has fallen more than 60% over the past year to $0.55. But the business has been reporting quick operational growth.

Doctor Care Anywhere is a UK-based telehealth company that wants to provide the best possible patient care and experience through its digital platform. It utilises its relationships with health insurers, healthcare providers and corporate customers to connect with patients to deliver a range of telehealth services.

For the three months to September 2021, the company saw quarter on quarter revenue growth of 21.6% to £5.8 million (A$10.7 million). This was driven by 30.6% growth of consultations to 116,800. Over 65% of consultations were delivered to returning patients.

It has also completed the acquisition of tele-health and tele-mental provider GP2U Telehealth. This expanded its operations to Australia, giving it geographic earnings diversification and another avenue for growth.

Excluding the impact of the acquisition, the ASX tech share has guided that FY21 revenue was going to grow by at least 100%.

It's also evolving its operating model so that it can offer not just a 15 or 20 minute virtual GP consultation, but also a 20 minute virtual consultation with an advanced nurse practitioner or a 'quick consult' where a patient completes a questionnaire to be reviewed by a prescribing clinician, resulting in written advice or a prescription without the need for a real time video or phone consultation.

Cettire Ltd (ASX: CTT)

Cettire is a global online retailer. It offers a large selection of in-demand personal luxury goods through its website, Cettire.com. The ASX share has an extensive catalogue of approximately 1,700 luxury brands and 200,000 products across clothing, shoes, bags and accessories.

The ASX tech share is experiencing rapid growth as more customers shop online due to the e-commerce tailwinds.

For the first four months of FY22 to 31 October 2021, sales revenue soared 172% to $57.8 million year on year, with the number of orders rising 209% to 107,676 and active customers soaring 220% to 158,260.

Cettire said that despite offline stores reopening with restrictions easing, its growth trajectory continues unabated.

The Cettire founder and CEO Dean Mintz said:

The focused investment to further enhance Cettire's solid foundations is delivering results. Having invested in customer acquisition and executed strongly, October monthly traffic increased 379% year on year. In addition, we are seeing very positive early signs from the migration to our proprietary storefront, with sales growth in "migrated" markets outpacing the company.

But the company is also looking to increase its total addressable market. It is looking to open up more potential revenue by exploring new adjacencies, such as the children's wear segment that it has recently launched.

Management are focused on operating Cettire to "maximise overall revenue growth".   

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Cettire Limited and Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended Cettire Limited and Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

A silhouette of a soldier flying a drone at sunset.
Technology Shares

Aussie defence stocks tick higher on bullish Trump comments

A massive increase in defence spending has been flagged.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Technology Shares

Is the WiseTech Global share price about to shock us all in 2026?

After a difficult year marked by uncertainty and execution risk, WiseTech enters 2026 with a clearer strategy and lower expectations.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Technology Shares

Guess which ASX 200 stock is rocketing 24% on impressive half year profit update

This growing company had another strong half. Here's what it expects to report next month.

Read more »

Doctor checking patient's spine x-ray image.
Technology Shares

This ASX technology company's shares are surging more than 20% on a new contract win

A new contract win has this company's management "excited".

Read more »

Man controlling a drone in the sky.
Technology Shares

This ASX tech stock is in focus after fresh US news

Elsight shares are in focus after the company secured a new US order, highlighting growing commercial adoption of its drone…

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

Two people in flying suits and helmets cruise in mid-air high above the earth with arms outstretched and the sun on the horizon.
Opinions

Prediction: WiseTech stock is going to soar past $150 in 2026

Here's what I expect from the stock in the next 12 months.

Read more »

Man on computer looking at graphs
Technology Shares

Down 36% in a year, is it time to consider buying shares in this dominant ASX tech company?

Is this ASX tech leader starting to look like a buying opportunity?

Read more »